Skip navigation
alt

Women’s health

Natera has solutions for all the steps in your journey to parenthood, from starting to plan a family to checking your baby’s health.
Natera has solutions for all the steps in your journey to parenthood, from starting to plan a family to checking your baby’s health.
Natera has solutions for all the steps in your journey to parenthood, from starting to plan a family to checking your baby’s health.
Natera has solutions for all the steps in your journey to parenthood, from starting to plan a family to checking your baby’s health.
Ma

On-Demand ASCO Presentations

ORAL PRESENTATION
POSTER PRESENTATION
  • From scientists, engineers and statisticians to lab associates, genetic counselors and medical educators, there are Naterans behind every test sample received, working to provide patients and providers insightful genetic information.

    ABSTRACT / POSTER: 4009 • 1
    Robert Schueren, Chief Operating Officer
    Deputy Global Head of Molecular Medicine Labs for Genentech, Inc
  • Our Oncology services give you the support you need to easily assimilate Signatera into your MRD assessment and surveillance workflows. Discover the tailored resources of NateraCore—accessible anytime, anyplace, so you can focus on patients.

    ABSTRACT / POSTER: 4009 • 1
    Steve Chapman, Chief Executive Officer
    Natera’s Chief Executive Officer, joined Natera in 2010
  • Our proprietary bioinformatics and extensive experience with cfDNA can provide you with highly accurate transplant evaluation results. Our mission is to help you determine the best medical course of action for your future. Prospera utilizes cutting-edge testing technology that can alert you to signs of organ rejection, increasing the odds that the kidney transplant will be successful. Talk to your doctor about whether Prospera is right for you.

    ABSTRACT / POSTER: 4009 • 1
    Mike Brophy, M.B.A.
    Mr. Brophy holds a master’s degree in business administration from the University of California, Los Angeles

Dive Deeper

For Clinicians

Circulating tumor DNA to detect minimal residual disease, response to adjuvant...
Report
Signatera Patient Brochure: Detect relapse or progression early
Brochure
Natera
Natera website

For Patients

Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early...
Poster
Employee Spotlight: Miriam De Leon
Blog
ESMO 2020 recap: cutting-edge cancer research in the COVID-19 era
Blog

For Others

Natera website
Website
Natera website
Website
Natera website
Website
icon-angle icon-bars icon-times